Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Gains from Investment Securities (2016 - 2025)

Tvardi Therapeutics' Gains from Investment Securities history spans 12 years, with the latest figure at $100000.0 for Q3 2025.

  • On a quarterly basis, Gains from Investment Securities changed N/A to $100000.0 in Q3 2025 year-over-year; TTM through Dec 2025 was $100000.0, a 89.64% decrease, with the full-year FY2025 number at $505440.0, up 14978.76% from a year prior.
  • Gains from Investment Securities hit $100000.0 in Q3 2025 for Tvardi Therapeutics, down from $1.2 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for TVRD hit a ceiling of $9.0 million in Q1 2023 and a floor of $3352.0 in Q2 2024.
  • Historically, Gains from Investment Securities has averaged $2.8 million across 5 years, with a median of $776569.0 in 2021.
  • Biggest five-year swings in Gains from Investment Securities: crashed 99.8% in 2022 and later surged 36196.0% in 2025.
  • Tracing TVRD's Gains from Investment Securities over 5 years: stood at $895000.0 in 2021, then fell by 28.4% to $640787.0 in 2022, then increased by 2.71% to $658138.0 in 2023, then tumbled by 99.49% to $3352.0 in 2024, then soared by 2883.29% to $100000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for TVRD at $100000.0 in Q3 2025, $1.2 million in Q2 2025, and $113487.0 in Q1 2025.